prof. dr. R.A. (Robert) Schoevers

PhD projects, with expected/realised year of promotion

Version: August 2026

1. Marijke Muller. Subthreshold psychosis. 2^nd promotor (2026)
2. Jurriaan Strous: ketamine for suicidality; markers and mechanisms (2027) 1st promotor
3. Nina Schimmers: psychedelics for end of life distress (2027) 1st promotor
4. Juliana Lima Constantino; using real world data to improve the outcome of depression treatments (2027) 1st promotor
5. Gerben Ruesink; the pleasure circle; a neurobiological view, 1st promotor (2027)
6. Xiaodan Peng; prevention of mental disorders, 2^nd promotor (2027)
7. Martijn Godschalk: oral esketamine versus ECT for patients with treatment resistant depression (2028)
8. Gijs Roelandt: ketamine for suicidality; clinical aspects (2028)
9. Tina Drincic; neurobiology of MDD, 1^st promotor (2028)
10. Rosalie Fleurbaaij: oral esketamine versus ECT for patients with treatment resistant depression (2028)
11. Sara Massetti: mechanisms of antidepressant treatment, a cross-species perspective (2028)
12. Juliana Dean: predicting the course of depression in clinical care (2028)
13. Rutger Boesjes: sleep and depression; clinical and preclinical studies (2028).
14. Stephan Tap: psychedelic assisted treatment for end-of-life distress (2029)
15. Akib Khan: mechanisms of psychedelic-assisted treatments (2029)
16. David Wedema; From symptoms to stories; Patients’ perspectives on what helps recovery from depression and how it can be supported with a novel intervention, RUG, 1st promotor (2026)
17. Annemiek Kamstra: Dealing with the consequences of severe interpersonal trauma through inpatient DBT-PTSD, RUG, 2nd promotor (2026)
18. Jolien Veraart; Ketamine for depression: Moving from research to clinical practice RUG, 1st promotor (2026) (Cum Laude)
19. Astrid Lugtenburg; Cognitive determinants of late life depression Who and why? - Understanding the association between cognitive impairment and late life depression RUG, 2nd promotor (2026)
20. Mike Jentsch: Advancing the diagnosis of major depressive disorder by adding a biological perspective: key considerations for developing a biomarker panel for MDD, RUG, 1st promotor (2025)
21. Sanne Apeldoorn Oral esketamine for difficult-to-treat depression RUG, 1st promotor (2025) (cum laude)
22. Celien Tigchelaar: Liquid gold: Cerebrospinal fluid collection, composition and biomarkers, RUG, 2nd promotor (2025)
23. Joost Breeksema: Exploring inner depths: a qualitative investigation of patients lived experiences with psychedelic treatments of depression RUG, 1st promotor (2024)
24. Stella Druiven Chronotype, depression, and circadian treatment strategies: Bridging the gap between epidemiology and clinical practice RUG, 1st promotor (2025)
25. Lino von Klipstein The experience sampling method in mental health care: integrating research and practice RUG, 2nd promotor (2024)
26. Julian Burger: the future of case formulation in clinical psychology, RUG, 2nd promotor, 2023 (cum laude)
27. Ernst Horwitz Boundaries, transitions: Autism Spectrum Disorder in adolescents and adults RUG, 2nd promotor, 2023
28. Madelien van de Beek Mental health problems in Moroccan-Dutch people: a mixed-methods study into social determinants, experiences and explanations RUG, 1st promotor, 2022
29. Date van der Veen Anxiety in late-life depression RUG, 2nd promotor, 2022
30. Kaying Kan Going beyond cost-effectiveness: analyzing routine mental healthcare data and stakeholders perspectives to improve depression care RUG, 1st promotor, 2021
31. Anouk de Wit Can hormones get you down? studies on sex steroids and depression RUG, 1st promotor, 2021 (cum laude)
32. Lian Beijers Parsing the heterogeneity of Major Depression: Biological subtyping and other statistical approaches to unravel the causes of Major Depression RUG, 1st promotor, 2021
33. Iris Jonker Inflammation as a transdiagnostic factor in the development of psychopathology and somatic symptoms RUG, 1st promotor, 2021
34. Petra Havinga; Breaking the cycle? intergenerational transmission of depression/anxiety and opportunities for interventions RUG, 1st promotor, 2020
35. Dennis Raven; Wheres the need? the use of specialist mental health services in adolescence and young adulthood RUG, 2nd promotor, 2020
36. Hanneke Geugies Learning from reward and prediction: insights in mechanisms related to recurrence vulnerability and non-response in depression RUG, 1st promotor, 2020
37. Ella Bekhuis A body-mind map: epidemiological and clinical aspects of the relation between somatic, depressive and anxiety symptomatology RUG, 2nd promotor, 2020 (cum laude)
38. Ans Hovenkamp-Hermelink The long-term course of anxiety disorders: An epidemiological perspective RUG, 1st promotor, 2020
39. Stefan Knapen Rhythm & Blues RUG, 1st promotor, 2019
40. Anne van Gils Developing e-health applications to promote a patient-centered approach to medically unexplained symptoms RUG, 2nd promotor, 2019
41. Huifang Yin Epidemiology and treatment of mental disorders in a rapidly developing urban region in China: a study of prevalence, risk factors and e-applications RUG, 1st promotor, 2019
42. Chengao Yang An inflamed mood: studies on the role of inflammation in the pathophysiology and treatment outcome of major depressive disorder, RUG, 1st promotor, 2019
43. Claudia van Borkulo  Symptom network models in depression research RUG, 1st promotor, 2018 (cum laude)
44. Marije Swets Obsessive compulsive symptoms in psychotic disorders UVA Amsterdam, 2nd promotor, 2018
45. Mia Scheffers; Body image, psychopathology and psychomotor therapy 2018 RUG, 1st promotor.
46. Karlijn Becking MDD, Bipolar depression and inflammatory dysregulation RUG, 1st promotor, 2018
47. Katelijne van Emmerik – van Oortmerssen ADHD and Substance Use Disorder RUG, 1st promotor, 2018
48. Sjoerd van Belkum; Neuromodulation and depression RUG, 1st promotor, 2018
49. Anne Looijmans; Lifestyle interventions in psychiatry RUG, 1st promotor, 2018
50. Mirjam Simoons Monitoring Outcomes of Psychiatric Pharmacotherapy (MOPHAR) RUG, 2nd promotor, 2018
51. Koen Hogenelst Serotonin manipulations and social behavior RUG, 2nd promotor, 2017
52. Erin van Buel Towards a neurobiological view of depression RUG, 2nd promotor, 2017
53. Tjalling Holwerda Loneliness, depression and mortality Amsterdam VU, 1st promotor, 2017
54. Hanna van Loo; Data-driven subtypes of major depressive disorder, RUG, 1st promotor, 2015 (cum laude)
55. Radboud Marijnissen The weight of subclinical vascular disease & neuroticism in late-life depression, RUG, 2nd promotor, 2014
56. Marrit de Boer Antipsychotic treatment and sexual functioning: From mechanisms to clinical practice RUG, 1st promotor, 2014
57. Nadine Troquete START-ing Risk Assessment and Shared Care Planning in Out-patient Forensic Psychiatry.: Results from a cluster randomized controlled trial RUG, 2nd promotor, 2014
58. Jaap Peen Mental health and urbanization: An investigation of urban-rural and innner-city differences in psychiatric morbidity Amsterdam VU, copromotor, 2009
59. Henricus Van Exploring predictive factors in the treatment of major depression Amsterdam VU, copromotor, 2008
60. Saskia de Maat On the effectiveness of psychoanalytic psychotherapy Amsterdam VU, copromotor, 2007  
61. Simone Kool Comorbidity of Major Depression and Personality Disorders Amsterdam UVA, copromotor, 2005